Delivery Order SPE2DB22D9353-SPE2DB25FX1XV
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,330.50 on July 22, 2025, for the supply of Fasenra 30 mg/ml syringes. The contract, with an ultimate completion date of July 23, 2025, was issued without a set-aside designation and funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,887.00 by the Defense Logistics Agency (DLA) on August 27, 2025. The contract calls for the delivery of Fasenra 30 mg/ml syringes, a biologic medication used in the treatment of severe eosinophilic asthma. The award carries no set-aside designation and has an ultimate completion date of August 28, 2025, with performance...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,330.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Fasenra 30 mg/ml syringes, and is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that runs through December 31, 2025. This IDC, under the SPE2DB program, allows the DLA to issue...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,661.00 to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of FASENRA 30 MG/ML SYRINGEML, a specialty pharmaceutical product, with a performance period running through September 5, 2024. This delivery order contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that...
- The Defense Logistics Agency awarded a $19,548 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Fasenra 30 mg/ml syringes, with an ultimate completion date of September 19, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the contractor's Park Ridge facility and represents a discrete purchase under DMS Pharmaceutical...
- This firm fixed-price delivery order worth $2,443.50 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of FASENRA 30 MG/ML SYRINGEML, a specialty medication, with a completion date of September 9, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,550.00 by the Defense Logistics Agency (DLA) on September 12, 2025. The delivery order, which is scheduled for completion by October 3, 2025, covers the supply of FASENRA Pen 30 mg/mL, a prescription pharmaceutical product, with performance to take place in Conshohocken, Pennsylvania. This award was made without a...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide FASENRA 30 MG/ML SYRINGEML. The $39,096 delivery order has a completion date of October 30, 2023 and was awarded on October 27, 2023. DMS Pharmaceutical Group will supply the pharmaceutical item to DLA Troop Support Medical facilities from its place of performance in Park Ridge, Illinois. As a woman-owned small business, DMS...
- The Defense Logistics Agency awarded a delivery order valued at $7,330.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra 30 mg/ml syringes. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and was executed on July 22, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc. under their indefinite delivery contract for pharmaceutical supplies. This $4,887 delivery order is for Fasenra 30 mg/ml syringes to fulfill routine needs at military treatment facilities. As a woman-owned small business, DMS Pharmaceutical Group will provide the specified pharmaceutical item from their facilities in Park Ridge, Illinois by December 12, 2023. Under...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX1XVDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $39,096.00 by the Defense Logistics Agency (DLA) on June 11, 2025, for the supply of Fasenra 30 mg/ml syringes. This firm fixed-price delivery order, which is expected to be completed by June 12, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026. The award carries no set-aside designation, allowing the company to compete on an unrestricted basis despite its small business status. The place of performance is Park Ridge, Illinois. This delivery order reflects the company's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense healthcare facilities. DMS Pharmaceutical Group has demonstrated consistent success in securing contracts for diverse pharmaceutical products, ranging from specialty medications and biologics to vaccines and medical consumables. The Fasenra supply under this order will support military health facility operations, with the product delivery completing within one day of the award date, indicating urgent medical supply requirements within the DoD healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.1k | 6/11/25 |